Phibro Animal Health | PAHC - Loan Capital


Phibro Animal Health reported $597.68M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Align Technology USD 0 0 Dec/2024
ANI Pharmaceuticals USD 286M 5.84M Mar/2026
Assertio Holdings USD 39.17M 120K Sep/2025
Aurora Cannabis CAD 33.2M 1.79M Dec/2025
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Canopy Growth CAD 224.99M 1.34M Dec/2025
Eli Lilly USD 39.37B 1.5B Mar/2026
Henry Schein USD 2.33B 17M Mar/2026
Idexx Laboratories USD 299.85M 74.99M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Merck USD 46.67B 77M Mar/2026
Nektar Therapeutics USD 63.16M 44.35M Dec/2025
Pacira USD 367.66M 4.53M Mar/2026
Phibro Animal Health USD 597.68M 5.92M Mar/2026
Prestige Brands USD 1.01B 40.28M Mar/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Zoetis USD 9.04B 3M Mar/2026